Testing of urodynamic dysfunctions in patients with multiple sclerosis

Rade Babović; Saša Milićević; Saša Radovanović; Jasna Jančić

doi:10.2298/2161

Rade Babović Clinic for Rehabilitation “Dr Miroslav Zotović”, Belgrade, Serbia
Saša Milićević Clinic for Rehabilitation “Dr Miroslav Zotović”, Belgrade, Serbia
Saša Radovanović Institute for Medical Research, University of Belgrade, Belgrade, Serbia
Jasna Jančić Clinic of Neurology and Psychiatry for Children and Youth, Faculty of Medicine, University of Belgrade, Belgrade, Serbia

DOI: https://doi.org/10.2298/2161

Keywords: multiple sclerosis, urination disorders, urodynamics, electromyography,

Abstract

Background/Aim. Multiple sclerosis (MS) is a chronic autoimmune inflammatory disorder of the unknown origin leading to multifocal demyelization, axonal damage and the loss of the nervous tissue in various parts of the central nervous system. Most MS patients have decreased functionality of the bladder leading to various dysuria disorders during the course of the illness. However, in 2% of the cases dysuric problems are the first symptoms of the disease. Urodynamic testing could help to diagnose functional disorders of the lower urinary tract, which might not be otherwise possible by performing the standard invasive procedures or noninvasive scans, such us ultrasound, computed tomography or functional magnetic resonance imaging (fMRI). Methods. Urodynamic testing – cystometry with electromyographic (EMG) potentials from the external anal sphincter (EAS), was performed in 34 patients (25 female and 9 male patients). Those patients fulfilled Mc Donald’s multiple sclerosis criteria. The urodynamic values were compared to neurological signs and the present disease symptoms. Results. The MS patients with (27) and without (7) miction problems were tested. Detrusor hyperreflexia is the most common finding, present in 58.8% of the cases. More than a half of the patients have detrusor sphincter dissynergia. Conclusions. Urodynamic testing helps us to determine neurological disorders characteristics and to prepare an appropriate treatment plan. During the course of the disease different urodynamic disfunctions may occur as well as changes in the urinating functionality. The rationale for urodynamic testing in patients suffering from MS before any other treatment procedure is to confirm the diagnosis of dysuric disorders and to secure appropriate treatment.

Author Biography

Rade Babović, Clinic for Rehabilitation “Dr Miroslav Zotović”, Belgrade, Serbia

Fizikalna medicina i rehabilitacija. Prim dr sc. med.

References

Betts CD, D'Mellow MT, Fowler CJ. Urinary symptoms and the neurological features of bladder dysfunction in multiple sclero-sis. J Neurol Neurosurg Psychiatry 1993; 56(3): 245−50.

Awad SA, Gajewski JB, Sogbein SK, Murray TJ, Field CA. Rela-tionship between neurological and urological status in patients with multiple sclerosis. J Urol 1984; 132(3): 499−502.

Ciancio SJ, Mutchnik SE, Rivera V, Boone TB. Urodynamic pattern changes in multiple sclerosis. Urology 2001; 57(2): 239−45.

Litwiller SE, Frohman EM, Zimmern PE. Multiple sclerosis and the urologist. J Urol 1999; 161(3): 743−57.

Schoenburg HW, Gutrich J, Banno J. Urodynamic patterns in mul-tiple sclerosis. J Urol 1979; 122(5): 648−50.

Fingerman JS, Finkelstein LH. The overactive bladder in multiple sclerosis. J Am Osteopath Assoc 2000; 100(3 Suppl): S9−12.

Abrams P, Blaivas JG, Stanton SL, Andersen JT. The standardiza-tion of terminology of lower urinary tract function. The Inter-national Continence Society Committee on standardization of terminology. Scand J Urol Nephrol 1988; 114: 5−19.

Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21(2): 167−78.

Pannek J, Pieper P. Clinical usefulness of ambulatory urodynam-ics in the diagnosis and treatment of lower urinary tract dys-function. Scand J Urol Nephrol 2008; 42(5): 428−32.

Abrams P. Urodynamics. 3rd ed. London, UK: Springer-Verlag; 2006.

Araki I, Matsui M, Ozawa K, Takeda M, Kuno S. Relationship of bladder dysfunction to lesion site in multiple sclerosis. J Urol 2003; 169(4): 1384−7.

Fowler CJ, Panicker JN, Drake M, Harris C, Harrison SC, Kirby M, et al. A UK consensus on the management of the bladder in multiple sclerosis. J Neurol Neurosurg Psychiatry 2009; 80(5): 470−7.

Cho SY, Yi J, June S. The clinical significance of poor bladder compliance. Neurourol Urodyn 2009, 28(8): 1010−4.

Kabay SC, Yucel M, Kabay S. Acute effect of posterior tibial nerve stimulation on neurogenic detrusor overactivity in pa-tients with multiple sclerosis:Urodynamic study. Urology 2008; 71(4): 641−5.

McClurg D, Ashe RG, Marshall K, Lowe-Strong AS. Comparison of pelvic floor muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunc-tion in people with multiple sclerosis: A randomized pilot study. Neurourol Urodyn 2006; 25(4): 337−48.

Blaivas JG, Barbalias GA. Detrusor-external sphincter dyssyner-gia in men with multiple sclerosis: An ominous urologic condition. J Urol 1984; 131(1): 91−4.

De EJ, Patel CY, Tharian B, Westney OL, Graves DE, Hairston JC. Diagnostic discordance of electromyography (EMG) versus voiding cystourethrogram (VCUG) for detrusor-external sphincter dyssynergy (DESD). Neurourol Urodyn 2005; 24(7): 616−21.

Woodward S. Impact of neurological problems on urinary con-tinence. Br J Nurs 1996; 5(15): 906−13.

Panicker JN, Nagaraja D, Kovoor JM, Nair KP, Subbakrishna DK. Lower urinary tract dysfunction in acute disseminated ence-phalomyelitis. Mult Scler 2009; 15(9): 1118−22.

Nager CW, Kraus SR, Kenton K, Sirls L, Chai TC, Wai C, et al.. Urodynamics, the supine empty bladder stress test, and incon-tinence severity. Neurourol Urodyn 2010; 29(7): 1306−11.